320 related articles for article (PubMed ID: 16987644)
1. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis.
Bapela NB; Lall N; Fourie PB; Franzblau SG; Van Rensburg CE
Phytomedicine; 2006 Nov; 13(9-10):630-5. PubMed ID: 16987644
[TBL] [Abstract][Full Text] [Related]
2. Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.
Mahapatra A; Mativandlela SP; Binneman B; Fourie PB; Hamilton CJ; Meyer JJ; van der Kooy F; Houghton P; Lall N
Bioorg Med Chem; 2007 Dec; 15(24):7638-46. PubMed ID: 17888665
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of naphthoquinones and triterpenoids from Euclea natalensis root bark.
Weigenand O; Hussein AA; Lall N; Meyer JJ
J Nat Prod; 2004 Nov; 67(11):1936-8. PubMed ID: 15568795
[TBL] [Abstract][Full Text] [Related]
5. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Intracellular Activity of Antitubercular Constituents the Roots of Euclea natalensis.
Lall N; Meyer JJM; Wang Y; Bapela NB; van Rensburg CEJ; Fourie B; Franzblau SG
Pharm Biol; 2005; 43(4):353-357. PubMed ID: 28925832
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY
Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
[TBL] [Abstract][Full Text] [Related]
9. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
10. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
[TBL] [Abstract][Full Text] [Related]
11. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
Sood R; Rao M; Singhal S; Rattan A
Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
[TBL] [Abstract][Full Text] [Related]
12. In vitro 12(S)-HETE inhibitory activities of naphthoquinones isolated from the root bark of Euclea racemosa ssp. schimperi.
Wube AA; Streit B; Gibbons S; Asres K; Bucar F
J Ethnopharmacol; 2005 Nov; 102(2):191-6. PubMed ID: 16019177
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA
J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637
[TBL] [Abstract][Full Text] [Related]
14. In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates.
Rey-Jurado E; Tudó G; de la Bellacasa JP; Espasa M; González-Martín J
Int J Antimicrob Agents; 2013 Mar; 41(3):278-80. PubMed ID: 23312604
[TBL] [Abstract][Full Text] [Related]
15. Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases.
Jimenez-Arellanes A; Meckes M; Ramirez R; Torres J; Luna-Herrera J
Phytother Res; 2003 Sep; 17(8):903-8. PubMed ID: 13680821
[TBL] [Abstract][Full Text] [Related]
16. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
[TBL] [Abstract][Full Text] [Related]
17. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Bhusal Y; Shiohira CM; Yamane N
Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
[TBL] [Abstract][Full Text] [Related]
18. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].
Sayğan MB; Ocak F; Cesur S; Tarhan G; Ceyhan I; Gümüişlü F; Beker G; Güner U; Coşkun E
Mikrobiyol Bul; 2007 Jul; 41(3):403-9. PubMed ID: 17933251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
